Thursday, January 28, 2021

Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - World-news https://ift.tt/36lyTbO
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

"We'll Cross The Bridge When We Get There": S Jaishankar On 500% Tariff Threat Over Russian Oil

India is engaging with American lawmakers over concerns surrounding a new Russia sanctions bill introduced in the US Congress, Foreign Minis...